ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $422,000 | -85.8% | 5,000 | -94.4% | 0.03% | -93.7% |
| Q4 2015 | $2,972,000 | +340.9% | 90,000 | +309.1% | 0.44% | +80.2% |
| Q1 2015 | $674,000 | -39.8% | 22,000 | 0.0% | 0.25% | -52.9% |
| Q4 2014 | $1,119,000 | +13.1% | 22,000 | -12.0% | 0.52% | +6.5% |
| Q3 2014 | $989,000 | -8.2% | 25,000 | 0.0% | 0.49% | -33.6% |
| Q2 2014 | $1,077,000 | -51.0% | 25,000 | -54.5% | 0.74% | -52.9% |
| Q1 2014 | $2,199,000 | +34.3% | 55,000 | -8.3% | 1.57% | +480.8% |
| Q4 2013 | $1,637,000 | – | 60,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |